Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis update

5 Nov 2021

Abstract excerpt

OBJECTIVE: To evaluate the diagnostic performance of short state homeobox 2 (SHOX2) promoter methylation as biomarker for lung cancer identification through aggregating the open published data. METHODS: We did an electronic search in Pubmed, EMBASE, Ovid, Web of Science, Google Scholar, and the China National Knowledge Infrastructure (CNKI) to identify the publications related to SHOX2 promoter methylation and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Genomic variations and chromosomal abnormalities
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34741433
DOI: 10.1111/1759-7714.14206

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis updatePMID 34741433Read ↗

The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disordersSemantic proximity Read ↗

A systematic review and meta analysis of the valve of SHOX2 and RASSF1A gene methylation in bronchial elveslar lavage fluid in the diagnosis of lung cancerSemantic proximity Read ↗

DNA methylation analysis in plasma for early diagnosis in lung adenocarcinomaSemantic proximity Read ↗

DNA Methylation Analysis of the SHOX2 and RASSF1A Panel Using Cell-Free DNA in the Diagnosis of Malignant Pleural EffusionSemantic proximity Read ↗

A Panel of DNA Methylation Biomarkers for Detection and Improving Diagnostic Efficiency of Lung CancerSemantic proximity Read ↗

Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.Semantic proximity Read ↗

Combined Methylation of SHOX2 and RASSF1A Genes in Diagnosing Malignant Pleural EffusionSemantic proximity Read ↗

A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancerSemantic proximity Read ↗

The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung CancerSemantic proximity Read ↗

Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancerSemantic proximity Read ↗

A combined model of circulating tumor DNA methylated SHOX2/SCT/HOXA7 and clinical features facilitates the discrimination of malignant from benign pulmonary nodulesSemantic proximity Read ↗

Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.